Pharma/Fine Chemicals Roundup – July 24

NOVASEP EXPANDS HPAPI MANUFACTURING FACILITY IN FRANCE Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPIs) manufacturing capabilities at the company's Le Mans, France, facility. The investment is €3 million ($3.7 million). The plant's expansion is expected to be fully operational by the beginning of 2013, the company says. EUROPEAN API SALES TO REACH $38.25 BILLION BY 2017 The total revenue generated by the European active pharmaceutical ingredient (API) market was $26.28 billion in 2011 and is expected...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers